Charlottesville, VA, United States of America

Timothy L MacDonald

This inventor holds 57 USPTO granted patents and 7 published patent applications and 8 EPO patents, primarily in Sphingosine Kinase Inhibitors (CPC class C07D). Top assignees: University of Virginia Patent Foundation, The United States of America as Represented by the Department of Health, Allergan Sales, Inc.. Active years: 1996-2021.

USPTO Granted Patents = 57 (Patent Applications = 7)

% Patents Active = 75.4

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 3.2

ph-index = 13

Forward Citations = 552(Granted Patents)

Forward Citations (Not Self Cited) = 469(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

51 out of 1,037

University of Virginia Patent Foundation

patents

2 out of 1,217

The United States of America as Represented by the Department of Health

5. 2 out of 834,350

Other

patents

Years Active: 1996-2021

Loading Chart...

Areas of Expertise:

Sphingosine Kinase

Calcium Channel

A2A Adenosine Receptor

Insulin Secretion

Antimicrobials

Tuberculosis Treatment

Neuropathic Pain

Beta-Cell Protection

Phosphonate Derivatives

Sphingosine Agonists

Sphingosine Antagonists

Sphingosine 1-Phosphate

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11130750 - Calcium channel inhibitors (2021-09-28),

2. 10369120 - T type calcium channel inhibitors (2019-08-06),

3. 9908849 - Imidamide sphingosine kinase inhibitors (2018-03-06),

4. 9688668 - Long chain base sphingosine kinase inhibitors (2017-06-27),

5. 9421177 - Imidamide sphingosine kinase inhibitors (2016-08-23),

6. 9376430 - Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials (2016-06-28),

7. 9333193 - Compositions and methods for treating tuberculosis (2016-05-10),

8. 9278098 - Substituted phthalazines for inducing insulin secretion and protecting beta-cells (2016-03-08),

9. 9212127 - T type calcium channel inhibitors (2015-12-15),

10. 8987321 - Lisofylline analogs and methods for use (2015-03-24),

11. 8871764 - Lisofylline analogs and methods for use (2014-10-28),

12. 8835644 - Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials (2014-09-16),

13. 8686046 - Compositions and methods for inhibiting sphingosine kinase (2014-04-01),

14. 8481580 - Lisofylline analogs and methods for use (2013-07-09),

15. 8378100 - Phosphonate derivatives as autotaxin inhibitors (2013-02-19),

Title: Exploring the Innovative Inventor Timothy L MacDonald

Introduction: Timothy L MacDonald, a prolific inventor based in Charlottesville, VA, has truly made a mark in the field of patents with an impressive portfolio of 57 patents. His groundbreaking work has contributed significantly to the advancement of treatments for various diseases, including cancer.

Latest Patents: MacDonald's latest patents showcase his ingenuity in the development of novel calcium channel inhibitors. These inhibitors, such as carbamate analogs of mibefradil, have shown promise in blocking the activity of voltage-gated calcium channels, proving effective in the treatment of diseases like cancer. Additionally, his work on T type calcium channel inhibitors highlights his commitment to discovering innovative solutions for conditions associated with calcium influx via T type calcium channels.

Career Highlights: Timothy L MacDonald has been associated with renowned institutions such as the University of Virginia Patent Foundation, where his innovative research has flourished. His dedication to pushing the boundaries of scientific discovery has led to the successful filing of 57 patents, solidifying his reputation as a leading figure in the field of inventions.

Collaborations: Throughout his career, MacDonald has had the privilege of collaborating with esteemed professionals in the field. Notable colleagues include Kevin R Lynch and Joel M Linden, whose collective expertise has further enriched MacDonald's inventive endeavors. The collaborative efforts have undoubtedly fueled the success of his patented inventions.

Conclusion: In conclusion, Timothy L MacDonald stands as a testament to the power of innovation and perseverance in the realm of patent inventions. His remarkable contributions, particularly in the development of calcium channel inhibitors, have paved the way for groundbreaking advancements in disease treatments. As he continues to push the boundaries of scientific exploration, MacDonald's legacy as a visionary inventor only continues to grow.

(Note: This article has been crafted based on the information provided about inventor Timothy L MacDonald. For more detailed insights into his patents and collaborations, feel free to explore the wealth of information available on idiyas.com)